TRVN Trevena Inc Earnings per share growth this year
Trevena, Inc. is valued by physicians for its safe innovations in acute pain therapy. The YoY net income per share growth rate confirms this status, with the metric holding at 60.60. Development is based on the creation of CNS drugs in US centers. Research efficiency is being enhanced through the implementation of software robots for data digitization.
Analytical breakdowns and data insights for company Trevena, Inc (TRVN)
- stock value and consensus price forecast:
- market capitalization data:
- book capitalization information:
- debt burden and liquidity indicators:
- earnings and market multiples details:
TRVN - Company Net Income|Expected Net Income Trevena, Inc.|TRVN - Price to Earnings Ratio|Future Price to Earnings trevena.com|TRVN - Price/Earnings to Growth Ratio|Enterprise Value to Operating Income Before Depreciation Trevena, Inc.|TRVN - Profit before payment of interest, taxes and amortization|Earnings per share for the last 12 months Trevena|TRVN - Net earnings per share (EPS TTM)|Earnings per share growth in annualized terms for the last twelve months trevena.com|TRVN - Net earnings per share growth this year|Earnings growth forecast for next year Trevena, Inc.
- company sales and revenue statistics:
Fundamental valuation:TRVN, Trevena, Inc.
This indicator measures the annual growth of earnings per share, reflecting the market consensus regarding the efficiency of net income generation. Analyzing the metric's trajectory allows investors to identify asset overheating and adjust risk limits to avoid capital lock-up. The EPS growth trend compared to the same period last year demonstrates the extent to which the efforts of Trevena, Inc. (TRVN) management to bring drugs to market are converting into actual financial results.
Key competitors
Earnings per share growth rate in current year Biogen Idec (BIIB)|NBIX (neurocrine.com) - Earnings growth in current year|Earnings per share growth rate in current year regencellbioscience.com RGC|Net earnings per share growth this year AXSM (Axsome Therapeutics, Inc.)|ACAD (ACADIA Pharma) - Earnings per share increase in current year|Earnings growth in current year XENE (Xenon Pharmaceuticals Inc)|Net earnings per one share growth for the current year VKTX (Viking Pharma)|SUPN: Net earnings per share growth this year|Earnings per share increase in current year CPRX (catalystpharma.com)|DNLI: Earnings growth in current year|HRMY - Expected net earnings per share growth this year|Net earnings per share growth this year BHVN|AMLX: Earnings per share increase in current year|Earnings per share growth in current year Trevi Pharma (TRVI)|Expected net earnings per share growth this year praxismedicines.com|Earnings per share growth in current year Anavex AVXL|Expected net earnings per share growth this year CeriBell (CBLL)|PRTA - Earnings per share growth in current year|ALEC: Earnings per share growth in current year|Annexon (ANNX) - Earnings per share growth in current year|OMER: Net earnings per one share growth for the current year|NGNE (neurogene.com) - Earnings growth in current year|Earnings growth in current year AC Immune S.A.|Net earnings per share growth this year VYGR (Voyager Therapeutics, Inc.)|Net earnings per one share growth for the current year NMRA|Earnings per share growth in current year scilexholding.com SCLX|TVGN: Earnings per share growth this year|alphacognition.com - Earnings growth in current year|Cognition Therapeutics - Net earnings per one share growth for the current year|IKT: Earnings growth in current year|Net earnings per share growth this year Cassava Sciences, Inc.|ASRT (assertiotx.com) - Earnings growth in current year|Net earnings per share growth this year Coya Therapeutics (COYA)|Net earnings per share growth this year VTGN (Vistagen)|Expected net earnings per share growth this year Ovid Therapeutics Inc|Earnings growth in current year ABOS (Acumen Pharmaceuticals Inc.)|CRVO - Net earnings per share growth this year|Alterity Therapeutics Limited - Earnings growth in current year|Earnings per share growth rate in current year Clene Inc|PEPG: Earnings growth in current year|Net earnings per share growth this year jupiterneurosciences.com|RLMD (relmada.com) - Earnings growth in current year|Earnings growth in current year Annovis Bio Corporation|Earnings growth in current year GRCE|AIFF: Earnings per share trend in current year|Earnings per share growth in current year Klotho Neurosciences KLTO|NRSN: Earnings per share growth this year|RVPH: Net earnings per share growth this year|Expected net earnings per share growth this year MetaVia MTVA|neuraxis.com (NRXS) - Earnings per share growth in current year|Helius Medical Technologies Inc. - Earnings per share increase in current year|PASG (Passage Bio, Inc.) - Earnings growth in current year|bionomics.com.au - Earnings per share trend in current year|Earnings growth in current year NERV|ATHA (Athira) - Earnings per share increase in current year|Addex Therapeutics - Net earnings per share growth this year|ALZN - Net earnings per share growth this year|Cyclerion Therapeutics, Inc. - Earnings growth in current year|Earnings per share increase in current year PTIX (Protagenic Therapeutics, Inc.)|KTTA (pasitheaclinics.com) - Net earnings per share growth this year|Earnings per share growth this year CRGT|Net earnings per share growth this year ATXI|Net earnings per share growth this year Brainstorm Cell (BCLI)|Net earnings per share growth this year CARA (Cara Therapeutics, Inc.)|Net earnings per share growth this year Chromocell Therapeutics Corp CHRO|Earnings growth in current year ELYM (Eliem Therapeutics, Inc.)|Earnings growth in current year intracellulartherapies.com ITCI|Longboard Pharmaceuticals - Earnings growth in current year|Expected net earnings per share growth this year Marinus Pharmaceuticals, Inc. MRNS|NKGN: Earnings growth in current year|NeuroBo Pharmaceuticals Inc - Earnings per share increase in current year|SAGE (Sage Therapeutics Inc.) - Earnings growth in current year|Earnings per share growth this year SNPX (Neurotrope)|Earnings growth in current year VIGL|Net earnings per share growth this year Anew Medical, Inc. WENA|Earnings per share growth in current year Cerevel Therapeutics CERE
